- Beck/Herrmann blog post
- Recorder/law.com coverage
- DOJ press release
- press release by attorney for Scott Harkonen
- 2002 InterMune press release at issue in indictment
- follow-up 2003 InterMune press release on same drug treatment
- 2003 Milberg Weiss motion in related securities litigation; the case settled for $10.4 million in 2005, about 25 cents/share for an $8 stock-drop
- 2008 InterMune press release re indictment
- related 2004 NY Times article about lawsuit by former sales rep
- November 2005 InterMune 10-Q excerpt re pending litigation
- 2006 DOJ press release re related settlement of charges against InterMune
- Settlement of US ex rel. Gallagher v. InterMune
- 2007 InterMune press release discontinuing Phase 3 trials for drug
- Current InterMune website on IPF, which, given current monitoring oversight, presumably passes legal muster.
Linkwrap: former InterMune CEO indicted for wire fraud for off-label promotion
![]() |
Rafael Mangual Project Manager, Legal Policy rmangual@manhattan-institute.org |
![]() |
Communications Manhattan Institute communications@manhattan-institute.org |